Milestone Pharmaceuticals Inc. 拟通过Cantor Fitzgerald销售协议发行至多1亿美元普通股 - SEC备案文件披露

美股速递
May 14

根据提交给美国证券交易委员会(SEC)的文件披露,Milestone Pharmaceuticals Inc. 可能通过其与Cantor Fitzgerald & Co. 达成的股权分销销售协议,发行并出售价值最高达1亿美元的普通股。

该份备案文件显示,此次股份发行将依据一份市场销售协议执行。公司计划将此次发行所得的净收益用于一般企业用途,其中可能包括推进产品管线、临床开发、资本支出以及补充营运资金等。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10